
Home » LabCorp’s High-Throughput COVID-19 Test Gets FDA Authorization
LabCorp’s High-Throughput COVID-19 Test Gets FDA Authorization

October 6, 2020
LabCorp has received an Emergency Use Authorization (EUA) from the FDA for a high-throughput COVID-19 molecular test that doesn’t require reagents for extracting RNA from the samples.
The test instead uses a heat-based extraction process that is as sensitive at the conventional reagent-based extraction methods.
The innovative extraction method improves testing efficiency and reduces reliance on testing supplies, LabCorp said.
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr